July 13, 2022
Bankrupt DNA sequencing technology company GenapSys Inc. received permission on Wednesday from a Delaware court to access $1 million in debtor-in-possession financing that comes with a set of deadlines for approval of a Chapter 11 asset sale.
July 12, 2022
DNA sequencing technology developer GenapSys filed for Chapter 11 protection July 11 in the midst of costly litigation with the company's founder and former CEO and the associated operational and reputational challenges.
July 12, 2022
After years of feuding over control of the company and a recent Delaware Chancery Court order disqualifying or invalidating most current or proposed directors, gene sequencing venture GenapSys Inc. retreated into Chapter 11 in Delaware late Monday, aiming for a quick sale.